ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003

FDA Committee to Discuss Policy On Combinations

January 7, 1977

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

Panel To Hear Centers’ Problems Again; Alabama, Mayo Impress Site visitors

March 18, 1977

BCI Budget Chief Browning To Retire

January 12, 1979

In Brief: Kennedy’s Oversight Hearings Will Include Cancer Program, Important To Act Renewal

January 26, 1979